In the field of cardiomyopathies, the use of novel tracers targeted to specific pathways and receptors, such as myocardial angiotensin II receptor type 1 [147], could shed further light on potential cardiomyopathic mechanisms. The gene discussed is AGTR1; the disease is cardiomyopathy.